Gold dips as vaccine progress offset worries over rising cases
By Sumita Layek (Reuters) - Gold prices eased on Wednesday as optimism about Pfizer's successful vaccine trials countered concerns over rising coronavirus infections and bets for further economic support. Spot gold was down 0.3% to $1,872.38 per ounce by 01:57 p.m.
By Sumita Layek
(Reuters) - Gold prices eased on Wednesday as optimism about Pfizer's successful vaccine trials countered concerns over rising coronavirus infections and bets for further economic support.
"The rollout of positive vaccine developments is reducing gold's lure as a safe haven. (Although) it still seems to be in a trading range, the big moves up seem to be finished for now," said ED&F Man Capital Markets analyst Edward Meir.
U.S. drugmaker Pfizer Inc
"(Vaccines) seem to be progressing quickly and there are several others also in the pipeline ... that should help the global economy recover and be net bearish for gold. But in the meantime, the fact that we're not out of the woods yet and need more stimulus seems to be offering some support," Meir said.
Gold, considered a hedge against inflation and currency debasement, has gained 24% this year, benefiting from massive global stimulus and near zero-interest rates.
"It is worth recalling that the driver of investment flows into precious metals has ultimately been sourced from a powerful impulse lower in real rates," TD Securities said in a note.
"The U.S. Federal Reserve's continued attempt to spark higher inflation expectations should suppress real rates deeper into negative territory. This will continue to drive investment appetite for precious metals, as capital seeks to shelter itself from increasingly negative real rates."
The World Platinum Investment Council projected a market deficit in 2020 and 2021.
(Reporting by Sumita Layek in Bengaluru; Editing by Marguerita Choy and David Gregorio)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
STOCKHOLM/LONDON (Reuters) - Sweden's decision to ban China's Huawei from its 5G networks restricts free competition and trade, the head of rival telecoms equipment supplier Ericsson told the Financial Times. Swedish telecoms regulator PTS this month halted 5G spectrum auctions after a court suspended parts of its decision that had excluded Huawei from 5G networks over national security risks. "I belong in that category that believes competition makes us longer term a better company
By Devika Krishna Kumar NEW YORK (Reuters) - Oil prices firmed by about 1% on Wednesday on hopes OPEC and its allies will delay a planned increase in oil output and after Pfizer said its COVID-19 vaccine was more effective than previously reported. The market was also supported by a smaller-than-expected increase in U.S. crude stockpiles last week
By Marton Dunai and Alan Charlish BUDAPEST/WARSAW (Reuters) - The prime ministers of Poland and Hungary accused European Union countries of blackmail on Wednesday, digging their heels in after vetoing the bloc's budget and post-COVID recovery package. The two countries on Monday blocked the EU's 2021-2027 budget and the recovery plan, worth a combined 1.85 trillion euros ($2.2 trillion), because access to the funds would be conditional upon respecting the rule of law